Device Trial Radar · NCT04737421
A Clinical Study on Implants With TiUltra Technology and Associated Prosthetic Components
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,000
Actual
Start
May 26, 2021
Primary completion
May 31, 2029
Study completion May 31, 2029
Sponsor
- Lead sponsor
- Nobel BiocareNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 3, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
Summary
As written by the sponsor on the registry.
This is a multicenter, prospective, non-interventional study in which a total of 1000 subjects in need of a single, multiple or full arch restoration in any region of the mouth (healed or extracted) will be treated in up to 30 study centers. The primary aim of this study is to demonstrate non-inferiority of all NobelBiocare TiUltra implants to historic data from NobelActive TiUnite coated implant in terms of marginal bone level change over 5 years after final prosthetic delivery. Eligible subjects who provide their informed consent for participation will be enrolled into one of four groups, each sized to 250 individuals. They will be treated with the corresponding implant system assigned to the group. The allocation into a certain group is only driven by the subject's clinical and restorative requirement and standard of care at the enrolling study clinic. Each subject will be followed for 5 years after definitive prosthetic placement
Conditions
- Marginal Bone Level Change
Interventions
NobelActive TiUltra implantDevice
Subjects will be enrolled and treated with one of the above groups as per the their clinical requirement and standard of care of the clinic.
NobelParallel CC TiUltra implantsDevice
Subjects will be enrolled and treated with one of the above groups as per the their clinical requirement and standard of care of the clinic.
NobelReplace CC TiUltra implantsDevice
Subjects will be enrolled and treated with one of the above groups as per the their clinical requirement and standard of care of the clinic.
Nobel Biocare N1 TiUltra TCC implantsDevice
Subjects will be enrolled and treated with one of the above groups as per the their clinical requirement and standard of care of the clinic.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Marginal bone level changeTime frame: Definitive prosthetic delivery to 5-years follow-up
Locations
32 sites in 14 countries. Site status is shown where the registry gives one.
Madison Prosthodontics
Madison, Alabama
31 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.